Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Financial Post

Image Credit: Financial Post

Please find more details at Financial Post

Summary

A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes Evidence continues to support the modified exposure claim that Sci

Source: Financial Post

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!